Hemophilia B

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

FDA
FDA
FDA Warns Against Use of Homeopathic Teething Tablets and Gels               
10/03/2016
The FDA issued a statement regarding serious adverse events with homeopathic teething tablets and gels.
10/03/2016
FDA
FDA
FDA Warns Against Use of Homeopathic Teething Tablets and Gels               
10/03/2016
The FDA issued a statement regarding serious adverse events with homeopathic teething tablets and gels.
10/03/2016
FDA Alerts
FDA Alerts
FDA Approves Artificial Pancreas
09/30/2016
The FDA approved a system to automatically monitor glucose and administer basal insulin doses in individuals aged 14 and older with type 1 diabetes.
09/30/2016
FDA Alerts
FDA Alerts
FDA Approves Artificial Pancreas
09/30/2016
The FDA approved a system to automatically monitor glucose and administer basal insulin doses in individuals aged 14 and older with type 1 diabetes.
09/30/2016
FDA Alerts
FDA Alerts
FDA Approves Artificial Pancreas
09/30/2016
The FDA approved a system to automatically monitor glucose and administer basal insulin doses in individuals aged 14 and older with type 1 diabetes.
09/30/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Crohn Disease
09/26/2016
The FDA approved a biologic to treat adults with active Crohn disease who have failed or were intolerant to treatment with immunomodulators or corticosteroids.
09/26/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Crohn Disease
09/26/2016
The FDA approved a biologic to treat adults with active Crohn disease who have failed or were intolerant to treatment with immunomodulators or corticosteroids.
09/26/2016
FDA Alerts
FDA Alerts
FDA Approves New Option for Crohn Disease
09/26/2016
The FDA approved a biologic to treat adults with active Crohn disease who have failed or were intolerant to treatment with immunomodulators or corticosteroids.
09/26/2016
FDA Alerts
FDA Alerts
FDA Approves Adalimumab Biosimilar
09/26/2016
The FDA approved the biosimilar adalimumab-atto for the treatment of inflammatory diseases including RA, psoriatic arthritis, and Crohn's disease.
09/26/2016
FDA Alerts
FDA Alerts
FDA Approves Adalimumab Biosimilar
09/26/2016
The FDA approved the biosimilar adalimumab-atto for the treatment of inflammatory diseases including RA, psoriatic arthritis, and Crohn's disease.
09/26/2016